Health insurance company UnitedHealth (NYSE: UNH) will be reporting results this Tuesday morning. Here’s what you need to know.

UnitedHealth met analysts’ revenue expectations last quarter, reporting revenues of $113.2 billion, up 12.2% year on year. It was a mixed quarter for the company, with a narrow beat of analysts’ customer base estimates but revenue in line with analysts’ estimates. Its number of customers was flat at a total of 54.08 million.

Is UnitedHealth a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting UnitedHealth’s revenue to grow 12.7% year on year to $113.6 billion, improving from the 6.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.11 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. UnitedHealth has missed Wall Street’s revenue estimates five times over the last two years.

With UnitedHealth being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unravel for healthcare providers & services stocks. However, there has been positive investor sentiment in the segment, with share prices up 2.9% on average over the last month. UnitedHealth is up 7.9% during the same time and is heading into earnings with an average analyst price target of $393.77 (compared to the current share price of $355.06).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.